We observed varying amounts of TRIM42 protein in all 4 AML samples, but were not able to detect appreciable amounts of TRIM42 in our human tissues, which included the 3 main target organs for GvHD, colon, skin and liver. This evidence concerns the gene TRIM42 and graft versus host disease.